The cynomolgus monkey is used to study drug metabolism because of its evolutionary closeness to humans. Despite their importance, regional distribution of cytochrome P450 (CYP) enzymes including CYP3As in the liver and small intestine, the major sites of drug metabolism, has not been fully investigated in cynomolgus monkeys. In this study, we measured mRNA expression levels of 14 CYPs in the CYP1, 2, and 3 subfamilies, including orthologs of human CYP3A4 and CYP3A5, in the liver and small intestine of cynomolgus monkeys. Expression levels of each CYP mRNA in various regions of the liver were quantified and comparisons were made between the right lobe, quadrate lobe, left medial lobe, left lateral lobe, and caudate lobe and with four different sections of the right lobe. In the small intestine, the same mRNAs were measured in the duodenum and six different sections from the proximal jejunum to the distal ileum. Expression levels of the CYP mRNAs were not substantially different between liver samples, but varied between the different sections of the small intestine, including CYP3A4. These results suggest that analysis of distinct sections is required for a better understanding of cynomolgus monkey CYPs in the small intestine.
Introduction
Monkeys are the non-human primate species used for drug-safety evaluation and biotransformation studies in the pharmaceutical industry, because of their closeness to humans in the evolutionary tree. Functional and sequence similarities of cytochrome P450s (CYPs) have been observed between humans and cynomolgus monkeys. 1) When comparing the pharmacokinetic parameters of many xenobiotics in rats, dogs, monkeys, and humans, data obtained from monkeys have provided the most accurate prediction of human pharmacokinetics. 2) Taken together, monkeys are considered to be one of the most important animal species in drug metabolism studies.
In humans, approximately 80% of oxidative metabolism and approximately 50% of the overall elimination of commonly used drugs can be attributed to one or more of the various CYP enzymes, the majority of which belong to CYP1-3 subfamilies. 3) Among these, CYP3A subfamily is considered to be the most important of all human drug-metabolizing enzymes because this subfamily is involved in the biotransformation of approximately 50% of therapeutic drugs 4) and because CYP3A subfamily enzymes are the most abundant CYP subfamily expressed in the liver and small intestine. [5] [6] [7] [8] In the small intestine, the CYP3A enzyme is present in epithelial cells and its content is most abundant in the proximal portion and decreases to the distal portion along the small intestinal tract. 7, 9, 10) Small intestine CYP3A can substantially catalyze the metabolism of some orally administered drugs, such as cyclosporine, midazolam, and verapamil, contributing to overall first-pass metabolism. [11] [12] [13] The intestinal mucosa, therefore, is considered one of the most important extrahepatic sites of drug biotransformation. 14) The presence of CYP3A, likely including CYP3A4 and CYP3A5, has also been confirmed in the small intestine of cynomolgus monkeys, and its expression is highest in the duodenum, and decreases to the distal part of the ileum. 15) To our knowledge, this is the only study that has analyzed regional distribution of CYPs in the small intestine of cynomolgus monkeys. It should be noted that cynomolgus monkey CYP3A8, orthologous to human CYP3A4, is designated as CYP3A4 in this paper. This decision was made after consulting with the P450 Nomenclature Committee (http://drnelson.utmem.edu/ cytochromeP450). Studies using reverse transcription (RT)-polymerase chain reaction (PCR) and immunoblotting showed the expression of CYP1A1, CYP2B, CYP2C, CYP2D, and CYP3A in the rat small intestine. [16] [17] [18] CYP2B1 and CYP3A proteins were expressed in the duodenum and jejunum, but expression was absent in the ileum, whereas CYP2C6 and CYP2D1 were expressed in minor amounts in the ileum. 19) In human small intestine, CYP1A1, CYP1B1, CYP2C, CYP2D6, CYP2E1, CYP3A4, and CYP3A5 mRNA expression was detected, but only CYP1A1, CYP2C, and CYP3A4 were detectable as proteins.
10)
The absence of CYP3A5 protein expression was probably due to polymorphic expression of CYP3A5, as CYP3A5 protein was detected in a small percentage of Caucasians. 6, 20) The latter study showed that CYP3A4 was expressed more abundantly than CYP3A5 and that CYP3A predominates over other CYPs in small intestine CYP content, followed by CYP2C, CYP2J, and CYP2D. 6, 20) We have developed real-time RT-PCR methods to specifically measure CYP1A1, CYP1A2, CYP2A23,  CYP2A24, CYP2B6, CYP2C20, CYP2C43, CYP2C75,  CYP2C76, CYP2D17, CYP2E1, CYP2J2, CYP3A4 , and CYP3A5 mRNA expression in cynomolgus monkeys. These methods were utilized in this study to quantify expression of each CYP mRNA in various parts of the liver and small intestine to investigate regional differences in expression of these 14 CYP mRNAs.
Materials and Methods
Chemicals and reagents: TRIzol, SuperScript III RNaseH Reverse Transcriptase, and random primer were purchased from Invitrogen (Carlsbad, CA, USA). DNase I was purchased from Takara (Tokyo, Japan). RNeasy Mini Kit was purchased from Qiagen (Hilden, Germany). TaqMan Universal PCR Master Mix and SYBR Green PCR Master Mix were purchased from Applied Biosystems (Foster City, CA, USA). TaqMan probes were synthesized by Applied Biosystems and Biosearch Technologies Japan (Tokyo, Japan). All other chemicals used in this study, unless specified, were of analytical grade and commercially available.
Animals: Three male cynomolgus monkeys (5-8 years old, 4.1-6.2 kg) supplied by Guangxi Reserch Center of Primate Laboratory Animal (Guangxi, China) were housed in a temperature-and humidity-controlled room with a 12-h light/dark cycle and fed a standard animal diet (Teklad Global Certified 25% Protein Primate Diet; Harlan Sprague-Dawley, Indianapolis, IN, USA). Food was provided ad libitum except during the overnight fasting periods before sampling. This study has been reviewed and approved by the Institutional Animal Care and Use Committee of Shin Nippon Biomedical Laboratories, Ltd. (Kainan, Japan).
Tissue samples and RNA extraction: Tissue samples collected from various parts of the liver and small intestine of the three male cynomolgus monkeys were quickly frozen to prevent possible RNA degradation. Total RNA was prepared from each sample using RNeasy Mini Kit according to the manufacturer's protocol, and after treatment with DNase I according to the manufacturer's recommendation, was purified again using the RNeasy Mini Kit. Liver samples included quadrate lobe (L2), left medial lobe (L3), left lateral lobe (L4), and caudate lobe (L5). Samples were also collected from four different sections of the right lobe (L1a-L1d). Small intestine samples were prepared by scraping epithelial cells off of the duodenum (I1), jejunum, and ileum. Since the boundary of the jejunum and the ileum is somewhat vague, the part containing the jejunum and ileum was separated into six equal sections, from the proximal jejunum to the distal ileum, which were designated as I2-I7.
Measurement of CYP mRNAs: To measure mRNA expression, real-time RT-PCR was performed as described previously. 21, 22) Briefly, RT reaction was carried out using purified total RNA, a SuperScript III RNaseH Reverse Transcriptase, and random primer. Each cDNA was used for real-time PCR that was performed using the TaqMan Universal PCR Master Mix or SYBR Green PCR Master Mix with the ABI PRISM 7500 sequence detection system (Applied Biosystems) following the manufacturer's protocol. The primers and probes specific for each CYP mRNA ( Table 1) were designed using Primer Express (Applied Biosystems). The FAM-labeled probes were linked at the 3? end to either MGB or BHQ1, and used at 200 nM. Final concentrations of the primers were 100 nM for CYP2C76 mRNA, 200 nM for CYP2B6 mRNA, 600 nM for CYP2A23, CYP2E1, CYP2J2, and CYP3A4 mRNAs, and 300 nM for the remaining CYP mRNAs. Thermal cycler conditions were 2 min at 509 C and 10 min at 959 C, followed by 40 cycles of 15 s at 959 C and 1 min at 609 C. Absolute quantification of each mRNA was carried out with standard curves generated using serial dilutions of the plasmids containing the corresponding cDNA, and normalization of expression level with 18S rRNA level was performed as previously described. 21, 22) As the internal control 18S rRNA was used, since, in our hands, its expression levels were more stable in various tissues compared with other internal controls generally used. At least three amplifications were performed for each CYP mRNA. To make data comparisons easier, CYP1A1 mRNA level in L1a was adjusted to 1, and all other expression levels are shown as values relative to the CYP1A1 mRNA level in L1a. The primers and probes have been described previously for CYP2A23, CYP2E1, CYP2J2, CYP3A4, and CYP3A5 mRNA 22) and for CYP2C20, CYP2C43, CYP2C75, and CYP2C76 mRNAs. 21) Those of other CYP mRNAs were newly developed. The TaqMan probe was used to measure expression of all CYP mRNAs except CYP2B6 mRNA that was measured in the presence of SYBR green.
Results and Discussion
To determine the distribution of CYP mRNAs in the liver and small intestine of cynomolgus monkeys, realtime RT-PCR was performed using the probes and primers specific for each CYP mRNA. The mRNA expression of CYPs in the CYP1-3 subfamilies, considered to be essential for drug metabolism, was measured in cynomolgus monkeys, including CYP1A1, CYP1A2, CYP2A23, CYP2A24, CYP2B6, CYP2C20, CPY2C43, CYP2C75, CYP2C76, CYP2D17, CYP2E1, CYP2J2, CYP3A4, and CYP3A5. It should be noted that the specificity of each probe and primer pair among subfamily members has been confirmed by experiments using plasmids containing cDNA for all subfamily members identified at the time of the analysis (data not shown). Expression levels of CYP mRNAs were measured and compared in various parts of the liver and small intestine. Liver samples included the right lobe (L1a-L1d), the quadrate lobe (L2), left medial lobe (L3), left lateral lobe (L4), and caudate lobe (L5). Small intestine samples consisted of epithelial cells scraped from the duodenum (I1) and six different sections from the proximal jejunum to the distal ileum (I2-I7).
All CYP mRNAs were present in all the liver lobes and sections examined ( Table 2 , Supplemental Table 1 ). Differences in expression levels of each CYP mRNA, between liver lobes or between the four different sections of the right lobe were not substantial (Supplemental Table 1 ), including CYP3A4 and CYP3A5 mRNAs (Fig.  1) . In the liver (L1a data used as representative of the whole liver), CYP isoforms in descending order with respect to mean mRNA expression levels for the animals examined are as follows: CYP3A4, CYP2E1, CYP2B6, CYP2A24, CYP3A5, CYP2C43, CYP2A23, CYP2C76, CYP2C75, CYP2D17, CYP2C20, CYP2J2, CYP1A1, and CYP1A2 ( Table 2) . Predominant expression of CYP3A4 mRNA in cynomolgus monkey liver along with abundant expression of CYP2E1 mRNA, moderate expression of CYP2D17, CYP2J2, and CYP3A5 mRNAs, and low expression of CYP1A1 and CYP1A2 mRNAs were also reported previously.
23)
The expression level order of the moderately expressed CYP mRNAs differs somewhat between Nishimura's findings 23) and our own. This is possibly due to inter-animal variability and/or different probes and primers used for real-time RT-PCR.
In cynomolgus monkey liver, CYP3A, CYP2E1, and CYP2C apparently showed relatively high mRNA expression. Higher expression levels of CYP2E1 than CYP3A4 have been observed in human liver at the mRNA level. 2-4-28) In human liver, however, CYP3A, CYP2C, and CYP1A proteins, but not CYP2E1 protein, were abundantly expressed, constituting 40%, 25%, and 18% of total CYP protein content, respectively, 5) probably because in human liver, there is usually a direct correlation between CYP mRNA and CYP protein expression levels, except CYP2E1. 29, 30) Assuming that this holds true for cynomolgus monkeys, abundant expression of CYP3A and CYP2C in both humans and cynomolgus monkeys would indicate similarities in hepatic CYP content between the two species.
In cynomolgus monkey liver, CYP1A1 mRNA expression level was much higher than that of CYP1A2 as has been described previously. 23, 31) In contrast, in human liver CYP1A2 is the major CYP1A, whereas CYP1A1 is Absolute quantification of each mRNA was performed and the data were normalized as described in Materials and Methods. Expression of each CYP mRNA was measured in the eight liver samples; the right lobe (the four parts, L1a, L1b, L1c, L1d), quadrate lobe (L2), left medial lobe (L3), left lateral lobe (L4), and caudate lobe (L5), and small intestine samples; the duodenum (I1) and small intestinal tract from the jejunum to ileum, which were separated into six parts (I2-I7). Data of L1a, I1, I2, and I7 are shown here as representative of the liver, duodenum, jejunum, and ileum, respectively. Data represent means±SD of the three animals based on the three independent amplifications. CYP1A1 mRNA level in L1a was adjusted to 1, and all other expression levels are shown as values relative to the CYP1A1 mRNA level in L1a. All data can be found in Supplemental Table 1 . Fig. 1 . Expression levels of CYP mRNAs in various liver lobes of cynomolgus monkey 14 CYP mRNAs were measured in the right lobe (the four parts, L1a, L1b, L1c, L1d), quadrate lobe (L2), left medial lobe (L3), left lateral lobe (L4), and caudate lobe (L5). Since similar results were obtained for all CYP mRNAs, only the data of CYP3A4 and CYP3A5 mRNAs are presented in this figure. Absolute quantification of each CYP mRNA was performed, and the expression level was determined and adjusted as described in Materials and MethodsMaterials and Methods. Each expression level represents the average±SD of the three cynomolgus monkeys based on three independent amplifications.
not constitutively expressed although it is inducible by AhR agonists. Ethoxyresorufin O-deethylase activity was strongly inhibited by anti-CYP1A antiserum and a-napthoflavone in human liver microsomes, but only moderately inhibited in monkey liver microsomes. 32) This difference can be explained if CYPs other than CYP1As are also involved in ethoxyresorufin O-deethylase, similar to rats. 33) The differences in hepatic expression and enzyme properties of CYP1A between humans and cynomolgus monkeys might possibly account for differences in CYP1A-mediated drug metabolism between the two species.
The same 14 CYP mRNAs were measured in different sections of cynomolgus monkey small intestine. In all small intestine samples (I1-I7), all 14 CYP mRNAs were detected except for CYP1A2 ( Table 2, Supplemental  Table 1 ). A comparison of each CYP mRNA was made between the duodenum, jejunum, and ileum. To make the comparison clear, the most proximal portion of the jejunum (I2) and most distal portion of the ileum (I7) (designated as representative of the jejunum and ileum, respectively) were compared with the duodenum (I1). Although the trend of mRNA expression levels from the duodenum to ileum along the small intestinal tract varied depending on CYP mRNA, most CYP mRNAs were expressed abundantly in the duodenum or jejunum, as compared with the ileum, including CYP1A1, CYP2C75, and CYP3A4 mRNAs (Fig. 2) .
Of the 14 CYP mRNAs examined in cynomolgus monkey jejunum, CYP3A4 mRNA was expressed most abundantly ( Table 2 ). In the jejunum (I2), CYP isoforms in descending order with respect to mean mRNA expression levels are as follows: CYP3A4, CYP3A5, CYP2C75, CYP2J2, CYP2D17, CYP2C43, CYP1A1, CYP2A23/CYP2C76, CYP2B6, CYP2A24, CYP2C20, and CYP2E1 ( Table 2) . Predominant expression of CYP3A4 mRNA with respect to CYP3A5 and CYP2J2 mRNAs in the small intestine of cynomolgus monkeys, was also reported previously. 23) CYP3As appear to be the most abundant CYP subfamily in cynomolgus monkey liver and small intestine, similar to humans, indicating their importance for drug metabolism in cynomolgus monkeys. Moreover, CYP3A4 mRNA is more abundant than CYP3A5 mRNA in the liver and jejunum, possibly indicating that the CYP3A-mediated first-pass effect Fig. 2 . Expression levels of cynomolgus monkey CYP mRNAs along the entire small intestine The 14 CYP mRNAs were measured in duodenum (I1), jejunum, and ileum. The small intestinal tract from the jejunum to ileum was separated into the six parts, I2-I7. The data of CYP1A1, CYP2C75, CYP2J2, CYP3A4, and CYP3A5 mRNAs are presented in this figure. Absolute quantification of each CYP mRNA was carried out, and expression level was determined and adjusted as described in Materials and Methods. Each expression level represents the average±SD of the three cynomolgus monkeys based on the three independent amplifications.
might be largely due to CYP3A4.
In cynomolgus monkey jejunum, CYP3A mRNA apparently showed a relatively high expression, while CYP2C and CYP2J2 mRNAs appeared to be moderately expressed. In the proximal jejunum of humans, CYP3A protein was most abundantly expressed, followed by CYP2C and CYP2J2 proteins. 6) Assuming that CYP mRNA expression and CYP protein expression levels are correlated in the small intestine of cynomolgus monkeys, the abundant expression of CYP3A and moderate expression of CYP2C and CYP2J observed in the jejunum of both humans and cynomolgus monkeys would possibly indicate similarities in small intestine CYP content between the two species. Similar to humans, expression of CYP1A1 mRNA was much higher than expression of CYP1A2 mRNA ( Table 2) . Studies have shown that in humans, expression of CYP1A1 is highly variable in the small intestine, [34] [35] [36] but this could be due to samples being obtained from individuals taking CYP1A inducers either in medication or through diet. In this study, expression of CYP1A1 mRNA was relatively stable among the three cynomolgus monkeys examined, most likely as a result of avoiding consumption of CYP1A inducers.
The predominant CYP2C mRNA expressed in cynomolgus monkey small intestine was CYP2C75, which was expressed at greater levels than CYP2C20, CYP2C43, and CYP2C76 mRNAs ( Table 2 ). CYP2C75, highly homologous to human CYP2C9 and CYP2C19, partially shares metabolic properties with these human CYP2Cs, 37) including the ability to metabolize tolbutamide. 21) In human small intestine, CYP2C9 and CYP2C19 are expressed more abundantly than other CYP2C proteins, constituting 14% and 2% of total CYP content, respectively. 6) CYP2C9 is also abundantly expressed in the liver and its average microsomal content is lower in the small intestine than in the liver. 38) Moreover, metabolic activities of CYP2C9 and CYP2C19 are lower in the small intestine than in the liver. 39) These results suggest that the small intestine would contribute minimally to the first-pass metabolism of drugs that CYP2C9 and CYP2C19 metabolize. CYP2C75 mRNA is more abundant in liver than in jejunum ( Table 2 ), indicating that CYP2C75 might not contribute to overall first-pass metabolism in the small intestine, although it might play an important role for the first-pass metabolism of substrates ingested in very small amounts and absorbed slowly. 40) Along the small intestinal tract, cynomolgus monkey CYP3A4 mRNA was abundant in the duodenum and upper jejunum (I1-I3) and its expression decreased toward the distal ileum (Fig. 2) . A similar pattern of CYP3A expression was also observed at the protein level. 15) Similarly in rats 19) and humans, 7, 9, 10) CYP3A proteins are expressed more abundantly in the upper small intestine, but the expression decreases toward the lower small intestine. In contrast to CYP3A4 mRNA, the expression level of CYP3A5 mRNA appears to be constant from the duodenum to distal ileum (Fig. 2) , and was lower than that of CYP3A4 in the duodenum and jejunum, but was the most abundant CYP (of the 14 CYP mRNAs examined) in the distal ileum ( Table 2) . CYP3A5 mRNA expression level was comparable between the liver and small intestine, whereas the expression level of other CYP mRNAs including CYP3A4 was much higher in the liver than in the small intestine ( Table 2) . Moreover, total protein content of enterocyte microsomes decreases from the duodenum to ileum, and total P450 content, determined spectrally, decreases from the jejunum to the ileum in humans. 10) These results suggest that CYP3A5 might play important roles in the small intestine, especially in the ileum.
In humans, bioavailability of CYP3A substrates such as midazolam, cyclosporine, and verapamil is decreased possibly because of the first-pass metabolism in the small intestine. [11] [12] [13] In cynomolgus monkeys, CYP3A5 mRNA levels were comparable between the liver and jejunum ( Table 2) , possibly indicating that CYP3A5 could play a major role in the first-pass metabolism of these drugs, which are metabolized mainly by CYP3A5. In humans, CYP3A5 is important for some drugs to exert pharmacological effects. For example, dose normalized blood concentrations of tacrolimus, an immunosuppressive agent, were correlated with the expression of CYP3A5 genotype in patients who underwent kidney, heart, lung, or liver transplants, in that the concentrations were lower in the patients with CYP3A5*1/*1 and CYP3A5*1/*3 than in those patients with CYP3A5*3/*3.
41-45)
If cynomolgus monkey CYP3A5 also metabolizes drugs such as tacrolimus, CYP3A5 could play a major role in first-pass metabolism.
Although only three animals were analyzed in the present study, variations in mRNA expression levels were observed between the animals. This is due likely to the inter-animal differences, because cynomolgus monkeys are genetically diverse, as has been demonstrated by identification of a large number of genetic variants identified in this species and closely related rhesus monkeys, [46] [47] [48] including CYP genes. 49, 50) This variability seems to be less than that of human CYPs. For example, human CYP3A4 content in the liver and small intestine can vary more than 40-fold between individuals, 40) , and mRNA expression levels can vary 380-fold between individuals 51) or 118-fold 52) in the liver, whereas cynomolgus monkey CYP3A4 mRNA levels in this study varied only 6.0-fold at most in the liver and 9.1-fold in the jejunum. Although the extent of inter-animal variability in CYP mRNA expression needs to be examined using a larger number of animal samples, such variability appears to be less than that of human CYPs.
If the amount of CYPs varies between the sections of the liver or small intestine, the sample collection site would be critical for measurement of drug-metabolizing activities in cynomolgus monkeys. In this study, expression levels of all 14 CYP mRNAs did not vary substantially between the different liver lobes or between different sections within the same liver lobe. In preliminary experiments, we did not see much difference in enzymatic activities, between the same liver samples measured using typical substrates of human CYP1A, CYP2A, CYP2B, CYP2C, CYP2D, CYP2E, and CYP3A (unpublished data), indicating that either liver sample can be used to represent hepatic CYP mRNA level and possibly CYP enzyme activity. In contrast, expression of CYP mRNAs was highly variable between the different sections of the small intestine, indicating that the sample site of the small intestine in cynomolgus monkeys needs to be carefully selected for measurement of CYP mRNA levels and possibly CYP enzymatic activities. Enzymatic activities are under investigation using typical human CYP substrates in different sections of the small intestine of the cynomolgus monkey.
In this study, expression levels of 14 CYP mRNAs were measured and compared in various parts of cynomolgus monkey liver and small intestine, providing an overview of CYP mRNA expression in the liver and small intestine of cynomolgus monkeys. Among the 14 CYP mRNAs analyzed, most were expressed much more abundantly in the liver than in the small intestine, except CYP3A5 mRNA, which was expressed at comparable levels in both tissues. In the liver and jejunum, the most abundant CYP mRNA was CYP3A4 mRNA, while moderate expression of CYP2C and CYP2J2 was observed in the liver and jejunum and in the jejunum, respectively. All 14 CYP mRNAs were expressed at comparable levels between various liver lobes or different sections of the same lobe, whereas the expression levels of some CYP mRNAs varied substantially between different sections of the small intestine. CYP3A4 mRNA expression level decreases from the proximal end to the distal end along the entire small intestine, whereas that of CYP3A5 is relatively constant, making CYP3A5 mRNA the most abundant CYP mRNA in the distal ileum. Further investigation of protein expression and function of these 14 CYPs and transporters along the small intestinal tract, will be helpful to generate quantitative scaling factors for drug metabolism in cynomolgus monkey small intestine. Such data could prove useful when conducting drug metabolism studies in cynomolgus monkeys.
